Celyad Oncology (Celyad Oncology) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Celyad Oncology Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Celyad Oncology's cash flow from discontinued operations for the three months ended in Jun. 2023 was $0.00 Mil. It means Celyad Oncology received $0.00 Mil from the sale of part of business quarterly. Celyad Oncology's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Celyad Oncology Cash Flow from Discontinued Operations Historical Data

The historical data trend for Celyad Oncology's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celyad Oncology Cash Flow from Discontinued Operations Chart

Celyad Oncology Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Celyad Oncology Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Celyad Oncology Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Celyad Oncology Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Celyad Oncology's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Celyad Oncology (Celyad Oncology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celyad Oncology SA (OTCPK:CYADY) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

CYAD:Belgium

Address

Rue Edouard Belin 2, Axis Business Park, Brabant Wallon, Mont-Saint-Guibert, BEL, 1435

Website

https://www.celyad.com

Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies. The company focuses on solid tumors and hematological malignancies. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CAR-T Cell, THINK, CYAD01 - Deplethink, CYAD02 - Cycle1, CwalityCAR, CYAD-101, and new engagers. The firm has Cardiology and Immuno-oncology operating segments.